Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
November 08, 2022 at 03:43 am EST
Share
Dr. Lal PathLabs Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 5,338 million compared to INR 4,984 million a year ago. Revenue was INR 5,425 million compared to INR 5,127 million a year ago. Net income was INR 717 million compared to INR 950 million a year ago. Basic earnings per share from continuing operations was INR 8.64 compared to INR 11.49 a year ago. Diluted earnings per share from continuing operations was INR 8.6 compared to INR 11.45 a year ago.
For the six months, sales was INR 10,365 million compared to INR 11,050 million a year ago. Revenue was INR 10,535 million compared to INR 11,334 million a year ago. Net income was INR 1,294 million compared to INR 2,262 million a year ago. Basic earnings per share from continuing operations was INR 15.61 compared to INR 27.38 a year ago. Diluted earnings per share from continuing operations was INR 15.55 compared to INR 27.27 a year ago.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
